Major pathologic response to neoadjuvant pemb

<p style="text-align:start">In exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major pathologic response in more than half of surgical specimens taken from patients who had been treated with neoadjuvant (pre-operative) pembrolizumab.&nbsp;These and other results of the analyses are presented as a proffered paper (Abstract LBA48) at the European Society of Medical Oncology (ESMO) Congress 2023 in Madrid, Spain, on Monday, October 23, by Sapna P. Patel, MD, chair of the SWOG melanoma committee and associate professor of melanoma medical oncology at the University of Texas MD Anderson Cancer Center.</p>

Related Keywords

Texas , United States , Kenilworth , Utah , Northwell , Michigan , Spain , Madrid , Valencia , Carabobo , Venezuela , Vernonk Sondak , Michaelc Lowe , Aparna Hegde , Johnm Kirkwood , Kaiser Permanente , Thach Giao Truong , Elizabethi Buchbinder , Larissa Korde , G Paul Wright , Phyllis Gyorkey , Antoni Ribas , Victorg Prieto , Sapnap Patel , Megan Othus , Kari Kendra , Elad Sharon , John Hyngstrom , Sunandana Chandra , Craig Devoe , Data Management Center , Moffitt Cancer Center , University Of Utah Huntsman Cancer Institute , National Institutes Of Health , National Clinical Trials Network , Dana Farber Cancer Institute Harvard Center , University Hospitals Seidman Cancer Center , Community Oncology Research Program , National Cancer Institute Therapy Evaluation Program , Twitter , Jonsson Comprehensive Cancer Center , National Cancer Institute Clinical Trials Network , Cleveland Clinic Foundation , Northwell Health Cancer Institute , Cancer Research Network , Method Of Research , Ohio State University Wexner Medical Center , Spectrum Health , Emory University , Valerie Guild , Merck Co Inc , Samantha Guild , European Society Of Medical Oncology , Cancer Research Consortium Of West Michigan , National Cancer Institute , University Of Michigan , Development Agreement , University Of Texas Md Anderson Cancer Center , Northwestern University , University Of Alabama , European Society , Medical Oncology , New England Journal , Phyllis Gyorkey Chair , National Institutes , Research Network , Clinical Trials Network , Cooperative Research , Cancer Research Consortium , West Michigan , Utah Huntsman Cancer Institute , Christopher Lao , Dana Farber Cancer , Harvard Cancer Center , Pittsburgh Medical Center Hillman Cancer , James Moon , Oncology Research Program , Mon Oct , Valencia Auditorium ,